靶点针对疾病信息19(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
标题
内容
TARGETID
T52522
TARGNAME
Adrenergic receptor beta-2 (ADRB2)
INDICATI
Approved Conduction disorder [ICD-11: BC63]
INDICATI
Approved Preterm labour/delivery [ICD-11: JB00]
INDICATI
Approved Sleep-related breathing disorder [ICD-11: 7A4Z]
INDICATI
Phase 3 Breast cancer [ICD-11: 2C60-2C6Y]
INDICATI
Phase 3 Stomach cancer [ICD-11: 2B72]
INDICATI
Phase 2/3 Supraventricular tachyarrhythmia [ICD-11: BC81]
INDICATI
Phase 2 Cachexia [ICD-11: MG20]
INDICATI
Phase 2 Dermal/subcutaneous connective tissue atrophy/degeneration [ICD-11: EE40]
INDICATI
Phase 2 Skin and skin-structure infection [ICD-11: 1F28-1G0Z]
INDICATI
Phase 1 Bladder disorder [ICD-11: GC01]
INDICATI
Phase 1 Obesity [ICD-11: 5B80-5B81]
INDICATI
Discontinued in Preregistration Ejaculatory dysfunction [ICD-11: HA03]
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3